| Name | Title | Contact Details |
|---|
After coaching over 10,000 clients and students from 30 countries in the past 10 years, we are proud to be pioneering the new generation of health coaches who are changing the consciousness of the planet. Our curriculum is based on cutting-edge psychology, brain science, intuitive listening, habit change and healthy lifestyle design. Graduates of our school are some of the most successful Health Coaches in the world. Why? We believe health coaching is one of the most lucrative and fulfilling careers you can choose. We also believe that health coaching will change the consciousness of the planet. There are lots of decent coaches out there, but not that many truly masterful coaches. We want to change that. What you can expect from us is everything we`ve got to help you be successful, so that like our current students, 6 months from now you will look back on this moment as the best decision you ever made for your career and your own personal growth. Stacey Morgenstern and Carey Peters are the founders and primary teachers of Health Coach Institute, a world-class international coach training company in service of creating leaders in the art, science, and business of health coaching. With over 10,000 graduates from 30 countries, they are pioneering the new generation of aspiring health coaches who want to turn their holistic passion into a thriving, meaningful career that raises the consciousness of the planet.
Residence XII is a Kirkland, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).
DNA2.0 is a privately-held, leading synthetic genomics company, headquartered in Menlo Park, CA.
Trenton Orthopaedic Group, PA is a Trenton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.